Skip to main content
. Author manuscript; available in PMC: 2013 Aug 1.
Published in final edited form as: Anticancer Drugs. 2012 Aug;23(7):706–712. doi: 10.1097/CAD.0b013e3283531041

Figure 4.

Figure 4

Tube formation inhibition. Panel (A) illustrates the positive control, HUVEC cell on Matrigel in complete media without any peptide treatment; panel (B) the inhibition of tube formation with SP3019; and panel (C) with SP2000.